Related Experiment Video
Updated: Aug 14, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
In vitro resistance to human platelet microbicidal protein among urethral staphylococcal and enterococcal isolates
1Institute of Cellular and Intracellular Symbiosis, Russian Academy of Sciences, Orenburg, Russia. ubi@mail.orb.ru
Abstract:
The study was carried out to test the in vitro activity of human platelet microbicidal protein (hPMP) on most commonly isolated urethral pathogens and compare the same with clinical isolates from cases of chronic prostatitis (CP). Urethral isolates of Staphylococcus aureus (n=19), coagulase negative staphylococci (n=40) and Enterococcus faecalis (n=16) from patients with or without CP were tested. The hPMP susceptibility of bacterial strains was determined by exposing bacterial cells to serial dilutions of hPMP. A significantly higher proportion of CP-strains of coagulase negative staphylococci (91.3% vs 5.88%) was resistant to hPMP than was that of non-CP strains (P S.aureus studied, 77.8% were considered resistant to the bactericidal action of hPMP. All nine CP-strains of E.faecalis were highly resistant to hPMP. Most non-CP urethral isolates of S.aureus, coagulase negative staphylococci and E.faecalis were susceptible to the bactericidal action of hPMP, while CP isolates of all species were significantly more resistant to hPMP. Data from the present study may have significant implications in understanding the pathogenesis of CP.
Insights
Human platelet microbicidal protein (hPMP) shows reduced activity against common urethral pathogens isolated from chronic prostatitis (CP) patients. CP bacterial strains demonstrate significantly higher resistance to hPMP compared to non-CP strains.
Area of Science:
- Microbiology
- Urology
- Immunology
Background:
- Chronic prostatitis (CP) is often linked to bacterial infections.
- Human platelet microbicidal protein (hPMP) possesses known antimicrobial properties.
- Understanding pathogen resistance mechanisms is crucial for CP treatment.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of hPMP against common urethral pathogens.
- To compare the susceptibility of bacterial isolates from CP patients versus non-CP individuals to hPMP.
- To investigate the role of hPMP resistance in the pathogenesis of CP.
Main Methods:
- In vitro susceptibility testing of bacterial isolates (Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis) to hPMP.
- Serial dilution method used to determine hPMP minimum inhibitory concentrations.
- Comparison of hPMP resistance profiles between clinical isolates from CP and non-CP patients.
Main Results:
- CP isolates of coagulase-negative staphylococci showed significantly higher resistance to hPMP (91.3%) compared to non-CP isolates (5.88%).
- A high percentage of Staphylococcus aureus (77.8%) and all Enterococcus faecalis CP strains were resistant to hPMP.
- Most non-CP urethral isolates were susceptible to hPMP, while CP isolates exhibited significantly increased resistance across all tested species.
Conclusions:
- Bacterial pathogens associated with chronic prostatitis display heightened resistance to human platelet microbicidal protein (hPMP).
- The observed hPMP resistance in CP isolates may contribute to the understanding of chronic prostatitis pathogenesis.
- Further research into hPMP's role and pathogen resistance is warranted for potential therapeutic strategies in CP.
Related Concept Videos
Microbiota of the Urogenital Tract
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Urinary Tract Infection II: Pathophysiology
